In vitro assessments of antimicrobial activity - task area B

Ended Awarded Last action

Contract number
75N93019D00002
Awardee
Awarding agency
Task orders
3 $4,032,395 obligated

Award facts

Opportunity
Combined order value
  • $4,032,395 Current, with exercised options
  • $18,818,683 Potential, with all options
Last date to order 100% complete
IDV ceiling 13% used
$30,000,000.00
Maximum order
$30,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 27 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a multiple award indefinite delivery contract to the American Type Culture Collection for in vitro assessments of antimicrobial activity and related biological products and services. The master contract has a potential value of $30 million over its period of performance from January 2019 to January 2026.

Two task orders have been issued against the contract to date. A $3.08 million order was awarded in January 2022 for the production of well-characterized biosafety level three and four viral challenge materials at ATCC's Manassas, Virginia facility over 25 months. An earlier $2,500 firm fixed price order issued in January 2019 involves in vitro antimicrobial assessments to be completed by September 2020 at the same location. Neither task order utilized set-asides.

The original solicitation sought support for the NIH's infectious disease research through the contracted provision of reference microorganisms and other biological materials, as well as laboratory testing services. ATCC will leverage its capabilities in pathogen storage, processing of biospecimens, and manufacturing of products for vaccine, therapeutic and diagnostic development under the contract. Task orders to date further the goals of generating characterized viral reagents and conducting antimicrobial susceptibility screening.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
Texas Biomedical Research Institute THE PRODUCTION OF WELL CHARACTERIZED CHALLENGE MATERIAL OF BSL-3/4 VIRUSES. The production of well characterized challenge material of BSL-4 viruses. $7,448,145

Quick answers

Who was awarded contract 75N93019D00002?

75N93019D00002 was awarded to American Type Culture Collection by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 11, 2019.

How much is contract 75N93019D00002 worth?

Orders under 75N93019D00002 have obligated $4,032,395. Their combined potential value, with all options, is $18,818,683. 75N93019D00002's own ceiling is $30,000,000. A single order can be worth up to $30,000,000.

How many orders have been placed under contract 75N93019D00002?

3 orders have been placed under 75N93019D00002, the latest on February 29, 2024.

Who can order from contract 75N93019D00002?

75N93019D00002 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N93019D00002 part of a contract vehicle?

Yes. 75N93019D00002 is part of In Vitro Assessments of Antimicrobial Activity (IVAAA).

Was contract 75N93019D00002 competed?

The extent of competition for 75N93019D00002 was full and open competition. The government received 27 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV